B Cells--Tumors clinical trials at UCSF

1 in progress, 0 open to eligible people

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Sorry, in progress, not accepting new patients
First-in-human Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-001 given intravenously every 3 weeks.
San Francisco, California and other locations

Last updated: December 12, 2022